04/17/2026
and this is why it is so important if you are taking these drugs to make sure you are strength training and incorporating weight bearing exercises!! πππ
New 2026 studies presented at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting indicate that long-term GLP-1 receptor agonist use (like Ozempic, Wegovy) is associated with an increased risk of bone-related conditions, including a ~30% higher risk of osteoporosis and higher incidence of osteomalacia and gout over five years. Rapid weight loss is believed to drive this accelerated bone loss, particularly in non-diabetic patients.
Medical News Today
Medical News Today
+4
Key Findings from Recent Studies (March 2026):
Increased Risk: A study of nearly 150,000 patients showed a 29% higher risk of osteoporosis, 12% higher risk of gout, and >150% higher risk of osteomalacia.
Bone Density Loss: Research indicates that while GLP-1 drugs effectively reduce weight, they can lead to increased bone turnover, with higher bone resorption (breakdown) markers in patients with significant weight loss.
Diabetes vs. Non-Diabetes: A study noted greater total hip (TH) bone loss in patients without diabetes (-1%) compared to those with diabetes taking the medication, suggesting that the speed of weight loss is a key factor in bone density reduction.
Fracture Risk: Another study found a modest increase in fracture risk among patients over 65 taking GLP-1s, specifically linked to reduced bone density.
PubMed Central (PMC) (.gov)
PubMed Central (PMC) (.gov)
+4
Clinical Implications:
Bone Surveillance: Experts suggest monitoring bone health and density in patients on long-term GLP-1 therapy, particularly for those with pre-existing osteoporosis risk.
Mitigation Strategies: While the study did not specifically test interventions, weight-bearing exercise is typically recommended to counteract bone loss associated with weight reduction.
aaos-annualmeeting-presskit.org
aaos-annualmeeting-presskit.org
+4
These findings suggest that while GLP-1 receptor agonists are highly effective for weight loss, they may necessitate increased awareness of potential, long-term skeletal side effects.
NBC News
NBC News
The American Academy of Orthopaedic Surgeons 2026 Annual Meeting press kit, research news ideas and photos.